Adam Gazzaley

Last updated

Adam Gazzaley
Adam Gazzaley by Chris Michel in 2023 02.jpg
Born
Adam Gazzaley

(1968-12-29) December 29, 1968 (age 55)
Brooklyn, New York, U.S.
Alma mater Binghamton University, Mount Sinai School of Medicine
SpouseJo Gazzaley (m. 2016)
Scientific career
Fields Neuroscience
Institutions University of California, San Francisco

Adam Gazzaley (born December 29, 1968) is an American neuroscientist, author, photographer, entrepreneur and inventor. He is the founder and executive director of Neuroscape [1] and the David Dolby Distinguished Professor of Neurology, Physiology, and Psychiatry at University of California, San Francisco (UCSF). [2] He is co-founder and chief science advisor of Akili Interactive Labs [3] and JAZZ Venture Partners. [4] Gazzaley is the inventor of the first video game approved by the FDA as a medical treatment. [5] [6] He is a board of trustee member, science council member and fellow of the California Academy of Sciences. [7] He has authored over 180 scientific articles. [8]

Contents

Career

Early life

Gazzaley graduated from the Bronx High School of Science in 1986. He received a Bachelor of Science degree in biochemistry from Binghamton University in 1990, followed by MD and PhD degrees in neuroscience through the NIH-sponsored Medical Scientist Training Program at the Mount Sinai School of Medicine in New York. [9] His doctoral research on plasticity of glutamate receptors in the hippocampus and implications for cognitive changes in normal aging earned him the 1997 Krieg Cortical Scholar Award. [10] He completed an internship in internal medicine (1998–1999) and residency in neurology (1999–2002) at the University of Pennsylvania Health System. [11]

Following residency in 2002, Gazzaley had a research fellowship at the University of California, Berkeley, and simultaneously worked as attending neurologist at the Northern California VA Medical Center, UCSF Medical Center and completed a clinical fellowship in cognitive neurology at the University of California, San Francisco Memory and Aging Center where he became board-certified in neurology. [12]

Research

Gazzaley founded Gazzaley Lab at UCSF in 2006 [13] and the UCSF Neuroscience Imaging Center in 2007. His research approach uses a combination of human neurophysiological tools, including functional magnetic resonance imaging (fMRI), electroencephalography (EEG) and transcranial stimulation (TES). He used this approach to show that older adults exhibit neural deficits in suppressing distractions and also while multitasking. [14] [15] [16]

Several of Gazzaley's studies explore how cognitive abilities may be enhanced via engagement with custom designed video games, neurofeedback and TES. [13] In 2009 he designed a video game, NeuroRacer , to enhance cognitive abilities of older adults. In a study published in 2013 as the cover story of Nature he showed that the multitasking nature of the game caused improvements in tasks outside of the game involving working memory and sustained attention. [17]

He created the Neuroscape Lab [18] at UCSF , an environment designed to create and validate neurodiagnostics and neurotherapeutics using newly emerging technology. He developed the GlassBrain, a 3D MRI brain visualization that displays overlaid rhythmic brain activity in real-time using EEG recordings in collaboration with scientists at UCSD. [19] [20]

In 2016, he merged Gazzaley Lab, Neuroscience Imaging Center and Neuroscape Lab into one research center – Neuroscape [1] — with the mission of bridging technology and neuroscience to create real-world solutions to enhance brain function.

Industry

In 2001, Gazzaley founded his first company, Wanderings Inc, to sell fine art prints of his nature photography. [21]

In 2011, Gazzaley co-founded Akili Interactive Labs, [3] a company that develops, validates and distributes digital medicine via scientifically validated video games, [22] and serves as a board member and its chief science advisor. [23] On June 15, 2020, Akili's EndeavorRx was FDA-cleared as a prescription treatment for children with ADHD. [24] This landmark event marked the first FDA-cleared digital treatment for ADHD, and the first video game approved by the FDA as the treatment of any medical condition. It was reviewed through FDA's de novo pathway and so its clearance creates a new regulatory classification of medicine. [5]

In 2015, he co-founded JAZZ Venture Partners, a venture capital firm investing in experiential technology to improve human performance, and serves as its chief scientist. [4]

In 2016, Gazzaley co-founded Sensync, a company creating a sensory immersion vessel to offer a novel wellness treatment called the Deep Brain Massage. [25] He served as its chief science advisor until 2021 when the company was dissolved. [26]

Public and media appearances

Gazzaley has delivered over 700 talks around the world on his research and perspectives. His public speaking has been recognized by receiving the 2015 Science Educator Award by the Society for Neuroscience. [27]

He has been profiled in The New York Times , [28] [29] The New Yorker , [30] The Wall Street Journal , [31] [32] Time , [33] Discover , [34] Wired , [35] PBS, [36] NPR, [37] CNN, [38] [39] NBC Nightly News , [40] The Today Show , [41] and Good Morning America . [42] In 2013, he wrote and hosted the nationally televised, PBS-sponsored special, "The Distracted Mind with Dr. Adam Gazzaley". [43] [44] In 2014, he co-hosted TEDMED. [45] He has appeared in several TV documentaries. [46]

Awards and honors

Works

Book

Gazzaley authored The Distracted Mind: Ancient Brains in a High-Tech World, along with Dr. Larry Rosen. It was published by MIT Press in October 2016. ISBN   978-0-262-03494-4 It won the 2017 Prose Award in the category of Biomedicine and Neuroscience. [51]

Select research articles

Related Research Articles

<span class="mw-page-title-main">Attention deficit hyperactivity disorder</span> Neurodevelopmental disorder

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterised by executive dysfunction occasioning symptoms of inattention, hyperactivity, impulsivity and emotional dysregulation that are excessive and pervasive, impairing in multiple contexts, and otherwise age-inappropriate.

<span class="mw-page-title-main">Neurofeedback</span> Type of biofeedback

Neurofeedback is a form of biofeedback that uses electrical potentials in the brain to reinforce desired brain states through operant conditioning. This process is non-invasive and typically collects brain activity data using electroencephalography (EEG). Several neurofeedback protocols exist, with potential additional benefit from use of quantitative electroencephalography (QEEG) or functional magnetic resonance imaging (fMRI) to localize and personalize treatment. Related technologies include functional near-infrared spectroscopy-mediated (fNIRS) neurofeedback, hemoencephalography biofeedback (HEG), and fMRI biofeedback.

<span class="mw-page-title-main">Atomoxetine</span> Medication used to treat ADHD

Atomoxetine, sold under the brand name Strattera, is a medication used to treat attention deficit hyperactivity disorder (ADHD) and, to a lesser extent, cognitive disengagement syndrome. It may be used alone or along with psychostimulants. It is also used as a cognitive and executive functioning enhancer to improve self-motivation, persistence, attention, inhibition, and working memory. Use of atomoxetine is only recommended for those who are at least six years old. It is taken orally. Atomoxetine is a selective norepinephrine reuptake inhibitor and is believed to work by increasing norepinephrine and dopamine levels in the brain. The effectiveness of atomoxetine is comparable to the commonly prescribed stimulant medication methylphenidate.

<span class="mw-page-title-main">Adderall</span> Drug mixture used mainly to treat ADHD and narcolepsy

Adderall and Mydayis are trade names for a combination drug called mixed amphetamine salts containing four salts of amphetamine. The mixture is composed of equal parts racemic amphetamine and dextroamphetamine, which produces a (3:1) ratio between dextroamphetamine and levoamphetamine, the two enantiomers of amphetamine. Both enantiomers are stimulants, but differ enough to give Adderall an effects profile distinct from those of racemic amphetamine or dextroamphetamine, which are marketed as Evekeo and Dexedrine/Zenzedi, respectively. Adderall is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It is also used illicitly as an athletic performance enhancer, cognitive enhancer, appetite suppressant, and recreationally as a euphoriant. It is a central nervous system (CNS) stimulant of the phenethylamine class.

<span class="mw-page-title-main">Dopaminergic pathways</span> Projection neurons in the brain that synthesize and release dopamine

Dopaminergic pathways in the human brain are involved in both physiological and behavioral processes including movement, cognition, executive functions, reward, motivation, and neuroendocrine control. Each pathway is a set of projection neurons, consisting of individual dopaminergic neurons.

Neuroplasticity, also known as neural plasticity or brain plasticity, is the ability of neural networks in the brain to change through growth and reorganization. It is when the brain is rewired to function in some way that differs from how it previously functioned. These changes range from individual neuron pathways making new connections, to systematic adjustments like cortical remapping or neural oscillation. Other forms of neuroplasticity include homologous area adaptation, cross modal reassignment, map expansion, and compensatory masquerade. Examples of neuroplasticity include circuit and network changes that result from learning a new ability, information acquisition, environmental influences, practice, and psychological stress.

<span class="mw-page-title-main">Guanfacine</span> Medication used for high blood pressure and ADHD

Guanfacine, sold under the brand name Tenex (immediate-release) and Intuniv (extended-release) among others, is an oral alpha-2a agonist medication used to treat attention deficit hyperactivity disorder (ADHD) and high blood pressure. Guanfacine is FDA-approved for monotherapy treatment of ADHD, as well as being used for augmentation of other treatments, such as stimulants. Guanfacine is also used off-label to treat tic disorders, anxiety disorders, and post-traumatic stress disorder (PTSD).

<span class="mw-page-title-main">Adele Diamond</span> Neuroscientist

Adele Dorothy Diamond is a professor of neuroscience at the University of British Columbia, where she is currently a Tier 1 Canada Research Chair in Developmental Cognitive Neuroscience. One of the pioneers in the field of developmental cognitive neuroscience, Diamond researches how executive functions are affected by biological and environmental factors, especially in children. Her discoveries have improved treatment for disorders such as phenylketonuria and attention-deficit hyperactivity disorder, and they have impacted early education.

Michael Matthias Merzenich is an American neuroscientist and professor emeritus at the University of California, San Francisco. He took the sensory cortex maps developed by his predecessors and refined them using dense micro-electrode mapping techniques. Using this, he definitively showed there to be multiple somatotopic maps of the body in the postcentral sulcus, and multiple tonotopic maps of the acoustic inputs in the superior temporal plane.

Brain training is a program of regular activities purported to maintain or improve one's cognitive abilities. The phrase “cognitive ability” usually refers to components of fluid intelligence such as executive function and working memory. Cognitive training reflects a hypothesis that cognitive abilities can be maintained or improved by exercising the brain, analogous to the way physical fitness is improved by exercising the body. Cognitive training activities can take place in numerous modalities such as cardiovascular fitness training, playing online games or completing cognitive tasks in alignment with a training regimen, playing video games that require visuospatial reasoning, and engaging in novel activities such as dance, art, and music.

Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.

<span class="mw-page-title-main">Earl K. Miller</span>

Earl Keith Miller is a cognitive neuroscientist whose research focuses on neural mechanisms of cognitive, or executive, control. Earl K. Miller is the Picower Professor of Neuroscience with the Picower Institute for Learning and Memory and the Department of Brain and Cognitive Sciences at Massachusetts Institute of Technology. He is the Chief Scientist and co-founder of SplitSage. He is a co-founder of Neuroblox.

Working memory training is intended to improve a person's working memory. Working memory is a central intellectual faculty, linked to IQ, ageing, and mental health. It has been claimed that working memory training programs are effective means, both for treating specific medical conditions associated with working memory deficit, as and for general increase in cognitive capacity among healthy neurotypical adults.

<span class="mw-page-title-main">Cogmed</span> Cognitive training software program

Cogmed is a cognitive training software program created in the lab of Torkel Klingberg, a neuroscientist at the Karolinska Institute. Dr. Klingberg was using it to present working memory challenges to people while he studied their brains using fMRI, to try to learn about neuroplasticity. When the studies appeared to show that the challenges improved working memory, Klingberg founded Cogmed in 2001, with financial backing from the Karolinska Institute and venture capitalists.

Barbara Jacquelyn Sahakian, is professor of clinical neuropsychology at the department of psychiatry and Medical Research Council (MRC)/Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge. She is also an honorary clinical psychologist at Addenbrooke's Hospital, Cambridge. She has an international reputation in the fields of cognitive psychopharmacology, neuroethics, neuropsychology, neuropsychiatry and neuroimaging.

NeuroRacer is a video game designed by a team of researchers at the University of California, San Francisco led by Adam Gazzaley as a way to help with mental cognition. It was designed as an "Adam Gazzaley intervention" for "top-down modulation deficits in older adults." A study on 60- to 85-year-olds showed that the multitasking nature of the game caused improvements in tasks outside of the game involving working memory and sustained attention. The game is presented as a driving simulator. Gameplay involves driving a vehicle down windy roads and pushing buttons when a sign appears.

<span class="mw-page-title-main">Daphne Bavelier</span> French professor and cognitive neuroscientist

Daphné Bavelier is a French cognitive neuroscientist specialized in brain plasticity and learning. She is full Professor at the University of Geneva in the Faculty of Psychology and Educational Sciences. She heads the Brain and Learning lab at Campus Biotech in Geneva, Switzerland.

<span class="mw-page-title-main">Roi Cohen Kadosh</span> Israeli-British cognitive neuroscientist

Roi Cohen Kadosh is an Israeli-British cognitive neuroscientist notable for his work on numerical and mathematical cognition and learning and cognitive enhancement. He is a professor of Cognitive Neuroscience and the head of the School of Psychology at the University of Surrey.

<span class="mw-page-title-main">Michael Stryker</span> American neuroscientist

Michael Paul Stryker is an American neuroscientist specializing in studies of how spontaneous neural activity organizes connections in the developing mammalian brain, and for research on the organization, development, and plasticity of the visual system in the ferret and the mouse.

EndeavorRx is a video game used to treat Attention Deficit Hyperactivity Disorder developed by Akili Interactive. It was based on a prototype game called NeuroRacer. NeuroRacer was developed by Akili Interactive and researchers at the University of San Francisco. The game runs on an engine known as the Akili Selective Stimulus Management engine. EndeavorRx was known as AKL-T01 or Project: EVO ADHD Treatment during its development. On June 15, 2020, it became the first ever video game to be approved by the FDA. It was approved to be used as a treatment for children with ADHD with the age range of 8–12. Five studies on over 600 children were conducted to measure the effectiveness of EndeavorRx. They found "a 36% improvement in at least one objective measure of attention." The side effects found by the researchers include frustration, dizziness, headaches, and aggression.

References

  1. 1 2 "Neuroscape – Bridging the gap between technology and neuroscience".
  2. ↑ "Adam Gazzaley, M.D., PhD, UCSF".
  3. 1 2 "Akili Interactive".
  4. 1 2 "JAZZ Venture Partners – The Firm".
  5. 1 2 "FDA Permits Marketing of First Game-Based Digital Therapeutic to Improve Attention Function in Children with ADHD". Food and Drug Administration . June 17, 2020.
  6. ↑ "FDA Approves Video Game Based on UCSF Brain Research as ADHD Therapy for Kids". www.ucsf.edu.
  7. ↑ "The Academy welcomes twelve new members to its Board of Trustees".
  8. ↑ Search Results for author Gazzaley A on PubMed .
  9. ↑ "Medical Board of California, License Holder". Archived from the original on December 19, 2014. Retrieved December 18, 2014.
  10. ↑ "Krieg Cortical Scholar Award" . Retrieved December 18, 2014.
  11. ↑ "US News Doctors: Dr. Adam Howard Gazzaley" . Retrieved December 19, 2014.
  12. ↑ "ABPM American Board of Psychiatry and Neurology". Diplomate Verification. Retrieved December 18, 2014.
  13. 1 2 "Neuroscape – Bridging the gap between technology and neuroscience". Archived from the original on February 8, 2014. Retrieved December 19, 2014.
  14. ↑ Gazzaley, A.; Clapp, W.; Kelley, J.; McEvoy, K.; Knight, R. T.; d'Esposito, M. (2008). "Age-related top-down suppression deficit in the early stages of cortical visual memory processing". Proceedings of the National Academy of Sciences. 105 (35): 13122–6. Bibcode:2008PNAS..10513122G. doi: 10.1073/pnas.0806074105 . JSTOR   25464001. PMC   2529045 . PMID   18765818.
  15. ↑ Gazzaley, Adam; Cooney, Jeffrey W; Rissman, Jesse; d'Esposito, Mark (2005). "Top-down suppression deficit underlies working memory impairment in normal aging". Nature Neuroscience. 8 (10): 1298–300. doi:10.1038/nn1543. PMID   16158065. S2CID   205430780.
  16. ↑ Clapp, W. C.; Rubens, M. T.; Sabharwal, J.; Gazzaley, A. (2011). "Deficit in switching between functional brain networks underlies the impact of multitasking on working memory in older adults". Proceedings of the National Academy of Sciences. 108 (17): 7212–7. Bibcode:2011PNAS..108.7212C. doi: 10.1073/pnas.1015297108 . JSTOR   41242155. PMC   3084135 . PMID   21482762.
  17. ↑ Anguera, J. A.; Boccanfuso, J.; Rintoul, J. L.; Al-Hashimi, O.; Faraji, F.; Janowich, J.; Kong, E.; Larraburo, Y.; Rolle, C.; Johnston, E.; Gazzaley, A. (2013). "Video game training enhances cognitive control in older adults". Nature. 501 (7465): 97–101. Bibcode:2013Natur.501...97A. doi:10.1038/nature12486. PMC   3983066 . PMID   24005416.
  18. ↑ "Neuroscape Lab puts brain activity on vivid display". UCSF. May 19, 2014. Retrieved December 18, 2014.
  19. ↑ "Glass Brain". Archived from the original on December 19, 2014. Retrieved December 24, 2014.
  20. ↑ "'Glass Brain' Offers Tours of the Space between Your Ears". Scientific America. Retrieved December 24, 2014.
  21. ↑ "Wanderings".
  22. ↑ Gormley, Brian (July 31, 2012). "Games to Sharpen the Brain". The Wall Street Journal. Retrieved December 18, 2014.
  23. ↑ "Akili – Adam Gazzaley". Archived from the original on December 19, 2014. Retrieved December 19, 2014.
  24. ↑ "In a landmark decision, FDA greenlights a video game for kids with ADHD". June 15, 2020.
  25. ↑ "Four Seasons Resort Oahu at Ko Olina and Sensync Partner to Introduce the World's First Multi-Sensory Virtual Reality Wellness Experience: The Vessel, Featuring Deep Brain Massage". Four Seasons Press Room. Retrieved November 28, 2019.
  26. ↑ "Sensync".
  27. ↑ danablog505 (October 19, 2015). "Adam Gazzaley Receives SfN Science Educator Award".{{cite web}}: CS1 maint: numeric names: authors list (link)
  28. ↑ Clive Thompson (October 23, 2014). "Can Video Games Fend Off Mental Decline?". The New York Times.
  29. ↑ Matt Richtel (September 4, 2013). "A Multitasking Video Game Makes Old Brains Act Younger". The New York Times.
  30. ↑ Patricia Marx (July 22, 2013). "Mentally Fit – Workouts at the brain gym". The New Yorker.
  31. ↑ Evelyn M. Rusli (March 10, 2014). "Inside Mickey Hart's Brain: How Tech and Neuroscience Are Converging". The Wall Street Journal. Retrieved December 19, 2014.
  32. ↑ Brian Gormley (July 31, 2012). "Games to Sharpen the Brain". The Wall Street Journal. Retrieved December 19, 2014.
  33. ↑ Maia Szalavitz (September 4, 2013). "Teaching Old Brains New Tricks With a Videogame". Time.
  34. ↑ David Ewing Duncan. "Looking at Stress—and God—in the Human Brain". Discover. Retrieved December 19, 2014.
  35. ↑ Brandon Keim. "Brain Scans Show How Multitasking Is Harder for Seniors". Wired . Retrieved December 19, 2014.
  36. ↑ "Your devices are probably ruining your productivity. Here's why". PBS . October 17, 2016.
  37. ↑ Jon Hamilton. "Multitasking After 60: Video Game Boosts Focus, Mental Agility". NPR . Retrieved December 19, 2014.
  38. ↑ Elizabeth Landau. "Video game may help aging brain". CNN . Retrieved December 19, 2014.
  39. ↑ "Can video games take your brain to the next level? – CNN". CNN .
  40. ↑ "NBC Nightly News". NBC . Retrieved December 19, 2014.
  41. ↑ McFadden, Cynthia. "Can brain games keep aging minds young? There's an app for that!".
  42. ↑ "FDA approves video game for treating ADHD in kids". Good Morning America.
  43. ↑ "Santa Fe Productions – The Distracted Mind with Dr. Adam Gazzaley". Archived from the original on October 7, 2014. Retrieved December 19, 2014.
  44. ↑ "Raising awareness about the distracted mind (PBS special)". PBS. March 7, 2013. Retrieved December 18, 2014.
  45. ↑ "Adam Gazzaley".
  46. ↑ "Adam Gazzaley". IMDb .
  47. ↑ "Krieg Cortical Kudos Awards".
  48. ↑ "Cermak Award". Archived from the original on January 9, 2017. Retrieved January 8, 2017.
  49. ↑ "The ASCI's 2015 ballot results – The American Society for Clinical Investigation".
  50. ↑ "Society for Neuroscience".
  51. 1 2 "Prose Award Winners".
  52. ↑ "Fellows California Academy of Sciences".
  53. ↑ "2020 Global Gaming Citizen Honor". YouTube .
  54. ↑ "2021 America's Greatest Disruptors". Newsweek .
  55. ↑ "2022 World's Most Innovative Companies".
  56. ↑ "2022 AURORA Institute Prize".
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.